ChemoCentryx Inc.

NASDAQ: CCXI · Real-Time Price · USD
51.99
0.05 (0.10%)
At close: Oct 19, 2022, 10:00 PM

ChemoCentryx Revenue Breakdown

Period Ending Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Grant Revenue 300K 500K 200K
Grant Revenue Growth -40.00% +150.00% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 28.18M 26.01M 23.42M 19.6M 19.7M 16.13M 12.71M 10.3M 10.13M 8.67M 6.79M 6.12M 5.57M 5.5M 5.63M 5.37M 4.75M 4.66M 4.13M 3.62M 4.18M 4.57M 3.35M 3.07M 3.7M 4.08M 3.43M 3.81M 3.58M 3.69M
Selling, General, and Administrative Revenue Growth +8.33% +11.05% +19.52% -0.51% +22.11% +26.90% +23.37% +1.67% +16.94% +27.61% +11.05% +9.80% +1.25% -2.26% +4.75% +13.16% +1.89% +12.89% +13.91% -13.38% -8.51% +36.47% +9.05% -16.99% -9.35% +19.07% -10.00% +6.57% -3.06% n/a
Research and Development Revenue 14.36M 17.48M 18.77M 19.95M 20.85M 23.42M 21.23M 18.58M 18.76M 19.31M 19.2M 18.1M 17.62M 15.35M 15.1M 15.13M 17.76M 14.74M 12.88M 12.31M 14.33M 9.97M 9.25M 8.39M 9.06M 11.24M 8.23M 7.93M 8.6M 8.42M
Research and Development Revenue Growth -17.86% -6.90% -5.90% -4.34% -10.95% +10.32% +14.23% -0.96% -2.84% +0.57% +6.11% +2.68% +14.78% +1.68% -0.23% -14.78% +20.47% +14.45% +4.60% -14.06% +43.72% +7.80% +10.25% -7.43% -19.41% +36.63% +3.77% -7.80% +2.16% n/a